Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Nath Bio-Genes (India)'s Revenue for the
three
months ended in Jun. 2026 was ₹3,284 Mil. Nath Bio-Genes (India)'s average Accounts Receivable for the
three
months ended in Jun. 2026 was ₹854 Mil.
Hence, Nath Bio-Genes (India)'s Receivables Turnover for the
three
months ended in Jun. 2026 was 3.84.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Nath Bio-Genes (India) Receivables Turnover Related Terms
Nath Bio-Genes (India) Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Nath Bio-Genes (India)'s Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:537291 vs CTVA, CF, MOS: Receivables Turnover Comparison
For the Agricultural Inputs subindustry, Nath Bio-Genes (India)'s Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nath Bio-Genes (India) Receivables Turnover vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Nath Bio-Genes (India)'s Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Nath Bio-Genes (India)'s Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nath Bio-Genes (India) (BOM:537291) has a Receivables Turnover of 3.84 as of Jun. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Nath Bio-Genes (India) and its competitors. According to the industry distribution chart, Nath Bio-Genes (India) ranks #162 out of 245 companies in the Agriculture industry, placing it in the top 66.1%.
Is Nath Bio-Genes (India)'s Receivables Turnover too high?
Nath Bio-Genes (India)'s current Receivables Turnover is 3.84. The Agriculture industry median Receivables Turnover is 5.59. Nath Bio-Genes (India)'s value of 3.84 is 31.3% below this industry median. Based on the distribution chart, Nath Bio-Genes (India) ranks #162 out of 245 companies in the Agriculture industry, which is below the industry midpoint. Overall, Nath Bio-Genes (India) has a GF Score™ of 71/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Nath Bio-Genes (India)'s Receivables Turnover compare to CTVA and CF?
According to the Agriculture industry distribution chart, Nath Bio-Genes (India) ranks #162 out of 245 companies for Receivables Turnover. This places Nath Bio-Genes (India) in the lower half of its industry. The industry median Receivables Turnover is 5.59. Nath Bio-Genes (India)'s value of 3.84 is 31.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for an Agriculture company?
The median Receivables Turnover among Agriculture companies is 5.59, based on 245 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nath Bio-Genes (India)'s current Receivables Turnover of 3.84 is 31.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Nath Bio-Genes (India) and its competitors. For the Agriculture industry, the median Receivables Turnover is 5.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nath Bio-Genes (India)'s current Receivables Turnover is 3.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nath Bio-Genes (India) stock overvalued right now?
Based on GuruFocus' analysis, Nath Bio-Genes (India) (BOM:537291) is currently considered Possible Value Trap. The stock's GF Value™ is ₹263.45, compared to a current price of ₹157.35 — trading 40.3% below its estimated fair value. The current Receivables Turnover is 3.84 and 31.3% below the Agriculture industry median of 5.59. Nath Bio-Genes (India)'s overall GF Score™ is 71/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Nath Bio-Genes (India) (BOM:537291), the current Receivables Turnover is 3.84 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nath Bio-Genes (India) (BOM:537291) Overvalued in 2026?
Based on GuruFocus' analysis, Nath Bio-Genes (India) stock appears to be undervalued.
The current stock price of ₹157.35 is trading 40.3% below its estimated GF Value™ of ₹263.45.
GuruFocus considers Nath Bio-Genes (India) to be Possible Value Trap.
Key valuation signals for BOM:537291:
Receivables Turnover: 3.84
GF Value™: ₹263.45 vs. price of ₹157.35 (40.3% below fair value)
Industry Position: 31.3% below the Agriculture median (#162 of 245)
No single metric tells the full story. See the BOM:537291 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nath Bio-Genes (India) Ltd is engaged in the business of production, processing, and marketing of Hybrid and GM seeds. The company has a product range of field crops, vegetable crops, and micronutrient supplements. It has developed products across verticals of cotton, paddy, mustard, maize, okra, tomato, gourds, chili, and crop nutrition supplements. The operating segments of the group are Agriculture activities; and Trading activities, of which a majority of revenue is derived from the Agriculture activities segment. Geographically, the group has a business presence in India and other countries, of which key revenue is generated within India.
71GF Score
Get the complete analysis for BOM:537291
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:537291 has been successfully added to your 
